EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost-effectiveness of sentinel screening of endemic diseases alongside malaria diagnosis: A case study in schistosomiasis

Francesco Manca iD, Giorgio Ciminata iD, Eleanor Grieve, Julien Reboud, Jonathan Cooper, Emma McIntosh

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Francesco Manca und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of health and Wellbeing, University of Glasgow, Glasgow, United Kingdom. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Schistosomiasis, Malaria, Endemic Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council (EPSRC) Institutional Support Fund, European Union Horizon Europe, UKRI Innovate UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In countries where malaria is endemic, the use of rapid diagnostic tests(RDTs) has become routine, especially in rural settings. Such regions are characterised by often having other co-endemic infectious diseases, at high levels of prevalence.

Aim

To illustrate the potential added-value of "sentinel” screening for patients presenting for a routine diagnostic test for malaria, at healthcare facilities in Uganda.

Methods

We developed an economic model by combining two decision trees, one for malaria and a second for the co-endemic disease schistosomiasis. The integrated model was designed to inform policy strategies for the co-endemic disease in addition to malaria (i.e., whether to test opportunistically for schistosomiasis or use mass drug administration(MDA) as per usual practice).We performed the analysis on three comparators varying testing accuracy and costs.

Results

Sentinel screening can provide added value to the testing of patients compared with the status quo: when schistosomiasis prevalence is high then MDA is preferential; if low prevalence, treating no one is preferred. If the disease has average levels of prevalence, then a strategy involving testing is preferred. Prevalence thresholds driving the dominant strategy are dependent upon the model parameters, which are highly context specific. At average levels of prevalence for schistosomiasis and malaria for Uganda, adding a sentinel screening was cost-effective when the accuracy of test was higher than current diagnostics and when economies of scope were generated(Expected value clinical Information = 0.65$ per DALY averted, 137.91$ per correct diagnoses).Protocols using diagnostics with current accuracy levels were preferred only for levels of MDA coverage below 75%.

Conclusion

The importance of the epidemiological setting is crucial in determining the best cost-effective strategy for detecting endemic disease. Economies of scope can make sentinel screenings cost-effective strategies in specific contexts. Blanket thresholds recommended for MDA may not always be the preferred option for endemic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisSchistosomiasisMalariaEndemic DiseasesHumansUgandaFemaleMaleAdultChildAdolescentDiagnostic Tests, RoutineMiddle AgedChild, PreschoolYoung AdultPrevalenceMass ScreeningSentinel SurveillanceModels, EconomicAged

Autor:innen und Institutionen

  • School of health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
  • James Watt School of Engineering, University of Glasgow, Glasgow, United Kingdom.

ORCID-Profile: Francesco Manca, Giorgio Ciminata

Förderung

  • Engineering and Physical Sciences Research Council (EPSRC) Institutional Support Fund
  • European Union Horizon Europe
  • UKRI Innovate UK
  • National Institute for Health Research
  • Royal Academy of Engineering Research Chair in Global Health
  • NIH

Zitieren

APA

Manca, F., Ciminata, G., Grieve, E., Reboud, J., Cooper, J., & McIntosh, E. (2024). Cost-effectiveness of sentinel screening of endemic diseases alongside malaria diagnosis: A case study in schistosomiasis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012339

Vancouver

Manca F, Ciminata G, Grieve E, Reboud J, Cooper J, McIntosh E. Cost-effectiveness of sentinel screening of endemic diseases alongside malaria diagnosis: A case study in schistosomiasis. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012339

BibTeX
@article{Manca2024,
  author = {Manca, Francesco and Ciminata, Giorgio and Grieve, Eleanor and Reboud, Julien and Cooper, Jonathan and McIntosh, Emma},
  title = {Cost-effectiveness of sentinel screening of endemic diseases alongside malaria diagnosis: A case study in schistosomiasis},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012339}
}
Kostenlos starten →